Polymyxin
Top View
- Polymyxin B B
- Polymyxin B, a Cationic Polypeptide Antibiotic, Interacts with Various
- Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
- Antibiotics Currently in Clinical Development Note: This Data Visualization Was Updated in May 2017 with New Data
- Development of Antibiotics for Gram-Negatives: Where Now?
- Beta-Lactam & Other Cell Wall- & Membrane-Active Antibiotics
- Antibiotics Currently in Global Clinical Development Note: This Data Visualization Was Updated in September 2018 with New Data
- Burden and Current Global Management on GNB Infections: Lessons from the Global-PPS of Antimicrobial Consumption and Resistance in 335 Hospitals Worldwide
- Treatment of Carbapenem Resistant Gram Negative Infections
- Lactam-Specific Whole-Cell Biosensor in Bacillus Subtilis Nina Lautenschläger1,2, Philipp F
- Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
- Vancomycin Vancomycin Hydrochloride for Injection, USP Hydrochloride for Injection, USP ADD-Vantage™ Vials Rx Only ADD-Vantage™ Vials Rx Only
- Polymyxin Delivery Systems: Recent Advances and Challenges
- Β-Lactamase Inhibitors- the Next Generation….And Beyond?
- Polymyxin B for the Treatment of Acinetobacter
- 2019 Antibacterial Agents in Clinical Development
- Polymyxins and Bacterial Membranes: a Review of Antibacterial Activity and Mechanisms of Resistance
- The Efficacy and Safety of Topical Polymyxin B, Neomycin And